Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Apr;95(4):1561–1568. doi: 10.1172/JCI117829

Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy.

S Pion 1, P Fontaine 1, C Baron 1, M Gyger 1, C Perreault 1
PMCID: PMC295646  PMID: 7706462

Abstract

Numerous minor histocompatibility antigens (MiHAs) show tissue-specific expression and can induce vigorous T cell responses. They therefore represent attractive targets for leukemia immunotherapy mediated by adoptive transfer of T cells. The main objective of this work was to determine whether MiHAs expressed by normal hematopoietic cells were present on leukemic cells and whether they could trigger lysis by cytotoxic T lymphocytes (CTLs). CTL assays showed that mouse leukemic cells of both lymphoid and myeloid lineages were sensitive to CTLs targeted toward some but not all MiHAs. In four out of four strain combinations in which we primed CTLs against immunodominant MiHAs, effectors killed leukemic blasts, whereas no cytotoxicity was observed when CTLs were targeted toward four immunorecessive MiHAs. Testing of HPLC fractions obtained from normal and leukemic cells provided molecular evidence that leukemic blasts expressed only some of the MiHAs found on normal mouse hematopoietic cells. Decreased density of H-2 class I molecules at the surface of leukemic cells suggests that down-regulation of genes encoding either class I molecules or proteins involved in antigen processing played a role in the aberrant expression of MiHAs. In vivo resistance to the leukemic cells by various strains of mice correlated with in vitro CTL activity. These results show that leukemic cells express only some (immunodominant) MiHAs and suggest that this subset of MiHAs represent prime targets for adoptive immunotherapy.

Full text

PDF
1561

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ando K., Guidotti L. G., Wirth S., Ishikawa T., Missale G., Moriyama T., Schreiber R. D., Schlicht H. J., Huang S. N., Chisari F. V. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol. 1994 Apr 1;152(7):3245–3253. [PubMed] [Google Scholar]
  2. Antin J. H. Graft-versus-leukemia: no longer an epiphenomenon. Blood. 1993 Oct 15;82(8):2273–2277. [PubMed] [Google Scholar]
  3. Ashton-Rickardt P. G., Bandeira A., Delaney J. R., Van Kaer L., Pircher H. P., Zinkernagel R. M., Tonegawa S. Evidence for a differential avidity model of T cell selection in the thymus. Cell. 1994 Feb 25;76(4):651–663. doi: 10.1016/0092-8674(94)90505-3. [DOI] [PubMed] [Google Scholar]
  4. Boon T. Toward a genetic analysis of tumor rejection antigens. Adv Cancer Res. 1992;58:177–210. doi: 10.1016/s0065-230x(08)60295-x. [DOI] [PubMed] [Google Scholar]
  5. Bortin M. M., Truitt R. L., Rimm A. A., Bach F. H. Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity. Nature. 1979 Oct 11;281(5731):490–491. doi: 10.1038/281490a0. [DOI] [PubMed] [Google Scholar]
  6. Browning M. J., Krausa P., Rowan A., Bicknell D. C., Bodmer J. G., Bodmer W. F. Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2842–2845. doi: 10.1073/pnas.90.7.2842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Butturini A., Gale R. P. T cell depletion in bone marrow transplantation for leukemia: current results and future directions. Bone Marrow Transplant. 1988 May;3(3):185–192. [PubMed] [Google Scholar]
  8. Charak B. S., Brynes R. K., Katsuda S., Groshen S., Chen S. C., Mazumder A. Induction of graft versus leukemia effect in bone marrow transplantation: dosage and time schedule dependency of interleukin 2 therapy. Cancer Res. 1991 Apr 15;51(8):2015–2020. [PubMed] [Google Scholar]
  9. Davis A. P., Roopenian D. C. Complexity at the mouse minor histocompatibility locus H-4. Immunogenetics. 1990;31(1):7–12. doi: 10.1007/BF00702483. [DOI] [PubMed] [Google Scholar]
  10. Faber L. M., van Luxemburg-Heijs S. A., Willemze R., Falkenburg J. H. Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. J Exp Med. 1992 Nov 1;176(5):1283–1289. doi: 10.1084/jem.176.5.1283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Falkenburg J. H., Goselink H. M., van der Harst D., van Luxemburg-Heijs S. A., Kooy-Winkelaar Y. M., Faber L. M., de Kroon J., Brand A., Fibbe W. E., Willemze R. Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes. J Exp Med. 1991 Jul 1;174(1):27–33. doi: 10.1084/jem.174.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Garrido F., Cabrera T., Concha A., Glew S., Ruiz-Cabello F., Stern P. L. Natural history of HLA expression during tumour development. Immunol Today. 1993 Oct;14(10):491–499. doi: 10.1016/0167-5699(93)90264-L. [DOI] [PubMed] [Google Scholar]
  13. Germain R. N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 1994 Jan 28;76(2):287–299. doi: 10.1016/0092-8674(94)90336-0. [DOI] [PubMed] [Google Scholar]
  14. Griem P., Wallny H. J., Falk K., Rötzschke O., Arnold B., Schönrich G., Hämmerling G., Rammensee H. G. Uneven tissue distribution of minor histocompatibility proteins versus peptides is caused by MHC expression. Cell. 1991 May 17;65(4):633–640. doi: 10.1016/0092-8674(91)90095-g. [DOI] [PubMed] [Google Scholar]
  15. Hogquist K. A., Gavin M. A., Bevan M. J. Positive selection of CD8+ T cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture. J Exp Med. 1993 May 1;177(5):1469–1473. doi: 10.1084/jem.177.5.1469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Horowitz M. M., Gale R. P., Sondel P. M., Goldman J. M., Kersey J., Kolb H. J., Rimm A. A., Ringdén O., Rozman C., Speck B. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990 Feb 1;75(3):555–562. [PubMed] [Google Scholar]
  17. Kane K. P., Mescher M. F. Activation of CD8-dependent cytotoxic T lymphocyte adhesion and degranulation by peptide class I antigen complexes. J Immunol. 1993 Jun 1;150(11):4788–4797. [PubMed] [Google Scholar]
  18. Koeppen H., Acena M., Drolet A., Rowley D. A., Schreiber H. Tumors with reduced expression of a cytotoxic T lymphocyte recognized antigen lack immunogenicity but retain sensitivity to lysis by cytotoxic T lymphocytes. Eur J Immunol. 1993 Nov;23(11):2770–2776. doi: 10.1002/eji.1830231108. [DOI] [PubMed] [Google Scholar]
  19. Lai P. K. Antigen competition in cytotoxic T cell response to minor histocompatibility antigens. Transplantation. 1985 Jun;39(6):638–643. doi: 10.1097/00007890-198506000-00013. [DOI] [PubMed] [Google Scholar]
  20. Lindahl K. F. Minor histocompatibility antigens. Trends Genet. 1991 Jul;7(7):219–224. doi: 10.1016/0168-9525(91)90368-z. [DOI] [PubMed] [Google Scholar]
  21. Ljunggren H. G., Stam N. J., Ohlén C., Neefjes J. J., Höglund P., Heemels M. T., Bastin J., Schumacher T. N., Townsend A., Kärre K. Empty MHC class I molecules come out in the cold. Nature. 1990 Aug 2;346(6283):476–480. doi: 10.1038/346476a0. [DOI] [PubMed] [Google Scholar]
  22. Loveland B., Wang C. R., Yonekawa H., Hermel E., Lindahl K. F. Maternally transmitted histocompatibility antigen of mice: a hydrophobic peptide of a mitochondrially encoded protein. Cell. 1990 Mar 23;60(6):971–980. doi: 10.1016/0092-8674(90)90345-f. [DOI] [PubMed] [Google Scholar]
  23. Miconnet I., de la Selle V., Tucek C., Huchet R., Bonardelle D., Bruley-Rosset M. Tissue distribution and polymorphism of minor histocompatibility antigens involved in GVHR. Immunogenetics. 1994;39(3):178–186. doi: 10.1007/BF00241258. [DOI] [PubMed] [Google Scholar]
  24. Perreault C., Brochu S., Fontaine P., Tremblay N., Pion S. The role of MHC-associated self-peptides in transplantation and immunosurveillance. Clin Immunol Immunopathol. 1994 May;71(2):130–135. doi: 10.1006/clin.1994.1062. [DOI] [PubMed] [Google Scholar]
  25. Perreault C., Décary F., Brochu S., Gyger M., Bélanger R., Roy D. Minor histocompatibility antigens. Blood. 1990 Oct 1;76(7):1269–1280. [PubMed] [Google Scholar]
  26. Pozzi C., Peruccio D., Dall'Omo A. M., D'Alfonso S., Savoia P., Guerra M. G., Miniero R., Lecchi M., Resegotti L., Richiardi P. Altered expression of HLA-A,B specificities on acute lymphoid and myeloid leukaemia blasts. J Immunogenet. 1990 Jun;17(3):161–168. doi: 10.1111/j.1744-313x.1990.tb00868.x. [DOI] [PubMed] [Google Scholar]
  27. Rammensee H. G., Falk K., Rötzschke O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol. 1993;11:213–244. doi: 10.1146/annurev.iy.11.040193.001241. [DOI] [PubMed] [Google Scholar]
  28. Rammensee H. G., Schild H., Theopold U. Protein-specific cytotoxic T lymphocytes. Recognition of transfectants expressing intracellular, membrane-associated or secreted forms of beta-galactosidase. Immunogenetics. 1989;30(4):296–302. doi: 10.1007/BF02421334. [DOI] [PubMed] [Google Scholar]
  29. Restifo N. P., Esquivel F., Kawakami Y., Yewdell J. W., Mulé J. J., Rosenberg S. A., Bennink J. R. Identification of human cancers deficient in antigen processing. J Exp Med. 1993 Feb 1;177(2):265–272. doi: 10.1084/jem.177.2.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ritz J. Tumor immunity: will new keys unlock the door? J Clin Oncol. 1994 Feb;12(2):237–238. doi: 10.1200/JCO.1994.12.2.237. [DOI] [PubMed] [Google Scholar]
  31. Roopenian D. C., Davis A. P. Responses against antigens encoded by the H-3 histocompatibility locus: antigens stimulating class I MHC- and class II MHC-restricted T cells are encoded by separate genes. Immunogenetics. 1989;30(5):335–343. doi: 10.1007/BF02425273. [DOI] [PubMed] [Google Scholar]
  32. Roopenian D. C. What are minor histocompatibility loci? A new look at an old question. Immunol Today. 1992 Jan;13(1):7–10. doi: 10.1016/0167-5699(92)90197-F. [DOI] [PubMed] [Google Scholar]
  33. Storkus W. J., Zeh H. J., 3rd, Maeurer M. J., Salter R. D., Lotze M. T. Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. J Immunol. 1993 Oct 1;151(7):3719–3727. [PubMed] [Google Scholar]
  34. Tremblay N., Fontaine P., Perreault C. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes. Transplantation. 1994 Jul 15;58(1):59–67. [PubMed] [Google Scholar]
  35. Truitt R. L., Shih C. C., LeFever A. V. Manipulation of graft-versus-host disease for a graft-versus-leukemia effect after allogeneic bone marrow transplantation in AKR mice with spontaneous leukemia/lymphoma. Transplantation. 1986 Mar;41(3):301–310. doi: 10.1097/00007890-198603000-00005. [DOI] [PubMed] [Google Scholar]
  36. Truitt R. L., Shih C. Y., Lefever A. V., Tempelis L. D., Andreani M., Bortin M. M. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo. J Immunol. 1983 Oct;131(4):2050–2058. [PubMed] [Google Scholar]
  37. Tsioulias G. J., Triadafilopoulos G., Goldin E., Papavassiliou E. D., Rizos S., Bassioukas P., Rigas B. Expression of HLA class I antigens in sporadic adenomas and histologically normal mucosa of the colon. Cancer Res. 1993 May 15;53(10 Suppl):2374–2378. [PubMed] [Google Scholar]
  38. Vacchio M. S., Hodes R. J. Selective decreases in T cell receptor V beta expression. Decreased expression of specific V beta families is associated with expression of multiple MHC and non-MHC gene products. J Exp Med. 1989 Oct 1;170(4):1335–1346. doi: 10.1084/jem.170.4.1335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wallny H. J., Rammensee H. G. Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature. 1990 Jan 18;343(6255):275–278. doi: 10.1038/343275a0. [DOI] [PubMed] [Google Scholar]
  40. Wettstein P. J., Bailey D. W. Immunodominance in the immune response to "multiple" histocompatibility antigens. Immunogenetics. 1982;16(1):47–58. doi: 10.1007/BF00364441. [DOI] [PubMed] [Google Scholar]
  41. Wettstein P. J. Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. III. Single histocompatibility antigens dominate the male antigen. J Immunol. 1986 Oct 1;137(7):2073–2079. [PubMed] [Google Scholar]
  42. Yin L., Poirier G., Neth O., Hsuan J. J., Totty N. F., Stauss H. J. Few peptides dominate cytotoxic T lymphocyte responses to single and multiple minor histocompatibility antigens. Int Immunol. 1993 Sep;5(9):1003–1009. doi: 10.1093/intimm/5.9.1003. [DOI] [PubMed] [Google Scholar]
  43. de Bueger M., Bakker A., Van Rood J. J., Van der Woude F., Goulmy E. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol. 1992 Sep 1;149(5):1788–1794. [PubMed] [Google Scholar]
  44. van der Bruggen P., Van den Eynde B. Molecular definition of tumor antigens recognized by T lymphocytes. Curr Opin Immunol. 1992 Oct;4(5):608–612. doi: 10.1016/0952-7915(92)90035-d. [DOI] [PubMed] [Google Scholar]
  45. van der Harst D., Goulmy E., Falkenburg J. H., Kooij-Winkelaar Y. M., van Luxemburg-Heijs S. A., Goselink H. M., Brand A. Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood. 1994 Feb 15;83(4):1060–1066. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES